Trial
NCT00290706
A Phase I/II Trial of VELCADE & Gemcitabine for Patients With Relapsed or Refractory Aggressive B- and T-cell Non-Hodgkin's Lymphoma
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Northwestern University
Collaborators
Eli Lilly and Company; Millennium Pharmaceuticals, Inc.
Condition
Lymphoma
Intervention
bortezomib
Why stopped
Closed per Data Monitoring Committee due to lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-28